Back
Silvercorp Metals, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
69
SVM.TO
Silvercorp Metals, Inc.
Last Price:
$11.34
Seasonality Move:
36.48%
Buy
87
KYMR
Kymera Therapeutics, Inc.
Last Price:
$88.61
Seasonality Move:
10.35%
Buy
69
Silvercorp Metals, Inc. (SVM.TO)
is a Buy
Is Silvercorp Metals, Inc. a Buy, Sell or Hold?
-
The current Silvercorp Metals, Inc. [SVM.TO] share price is $11.77. The Score for SVM.TO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
SVM.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SVM.TO Stock Price Chart
What is Silvercorp Metals, Inc.'s stock price today?
-
The Silvercorp Metals, Inc. share price today is $11.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SVM.TO is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $87.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
SVM.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 73.48 | Buy |
| Chaikin Money Flow: | 431937 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.2 - 11.04) | Buy |
| Bollinger Bands (100): | (6.65 - 9.95) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.53 | Buy |
| Relative Strength Index (14 RSI): | 71.11 | Buy |
| Chaikin Money Flow: | -592960 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.18 - 78.14) | Buy |
| Bollinger Bands (100): | (43.11 - 66.09) | Buy |
SVM.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.19 | Buy |
| 20-day SMA: | 10.28 | Buy |
| 50-day SMA: | 9.72 | Buy |
| 200-day SMA: | 6.94 | Buy |
| 8-day EMA: | 11.17 | Buy |
| 20-day EMA: | 10.54 | Buy |
| 50-day EMA: | 9.65 | Buy |
| 200-day EMA: | 7.5 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.75 | Buy |
| 20-day SMA: | 70.43 | Buy |
| 50-day SMA: | 63.87 | Buy |
| 200-day SMA: | 45.05 | Buy |
| 8-day EMA: | 80.77 | Buy |
| 20-day EMA: | 72.92 | Buy |
| 50-day EMA: | 64.9 | Buy |
| 200-day EMA: | 50.57 | Buy |
Silvercorp Metals, Inc. Earnings Growth & SVM.TO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.25 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.
Silvercorp Metals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||